Own investment based stock option plan to Okmetic management

OKMETIC OYJ STOCK EXCHANGE RELEASE    18 DECEMBER 2013 AT 9.30 A.M. Based on the authorization given by the Annual General Meeting held on April 10, 2013, Okmetic Board of Directors has decided to grant stock options to the key managers of Okmetic. Investment requirement As a precondition for being eligible to receive the stock options, the key managers are required to invest in Okmetic shares. According to the investment requirement, the key managers are required to hold in the aggregate 262,600 Okmetic shares to be eligible to receive all of the stock options. Stock options The stock options shall, in deviation from the shareholders' pre-emptive subscription right, be offered to the key managers of Okmetic. The maximum total number of stock options offered is 870,000, which entitle participants to subscribe for a maximum number of 870,000 Okmetic shares (4.8% of the company's shares on a fully diluted basis). Each stock option entitles participants to subscribe for one share. The shares subscribed with the stock options may either be new shares issued by the company or existing shares held by the company. Of the stock options, 320,000 shall be marked with the symbol 2013 A and 550,000 with the symbol 2013 B. The stock options shall be issued free of charge. The share subscription price for the stock options 2013 A shall be euro 5.75 (approximately 20% above current share price) and for the stock options 2013 B euro 6.00 (approximately 25% above current share price). Future dividends and capital repayments from the invested unrestricted equity reserve distributed before the share subscription shall be deducted from the share subscription price. The share subscription period for 25% of the stock options 2013 A and 2013 B will commence on or about February 1, 2016 and for 75% of the stock options 2013 A and 2013 B on or about February 1, 2017. The share subscription period for all the stock options ends on March 31, 2018. Grounds for deviation from shareholders' pre-emptive subscription right There is, for the company and in the interest of all the company's shareholders, a substantial financial ground to grant the stock options in deviation from the shareholders' pre-emptive subscription right, since the stock options are intended to align the interests of the shareholders and the key managers and to form a part of the incentive and commitment program of the key managers. The purpose of the arrangement is to encourage the key managers to invest in the company's shares and to work on a long-term basis to increase the company's share value. OKMETIC OYJ Board of Directors For further information, please contact: Senior Vice President, Finance, IT, and Communications Juha Jaatinen, Okmetic Oyj, tel. +358 9 5028 0286, email: juha.jaatinen@okmetic.com Distribution: NASDAQ OMX Helsinki Principal media www.okmetic.com OKMETIC IN BRIEF Take it higher Okmetic is a technology company which supplies tailor-made silicon wafers for sensor and semiconductor industries and sells its technological expertise. Okmetic provides its customers with solutions that boost their competitiveness and profitability. Okmetic's silicon wafers are part of a further processing chain that produces end products that improve human interaction and quality of life. Okmetic's products are based on high-tech expertise that generates added value for customers, innovative product development and an extremely efficient production process. Okmetic has a global customer base and sales network, production plants in Finland and the US and contract manufacturers in Japan and China. Okmetic's shares are listed on NASDAQ OMX Helsinki under the code OKM1V. For more information on the company, please visit our website at www.okmetic.com. Own investment based stock option plan to Okmetic management: http://hugin.info/132025/R/1750634/590029.pdf This announcement is distributed by GlobeNewswire on behalf of GlobeNewswire clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Okmetic Oyj via GlobeNewswire [HUG#1750634]